| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr11:9282084-9282363:- | ENST00000524543.4 | ENSG00000166471.9 | TMEM41B | UTR3 | AluSx | chr11:9282084-9282363:-.alignment |
| chr11:9282084-9282363:- | ENST00000528080.4 | ENSG00000166471.9 | TMEM41B | UTR3 | AluSx | chr11:9282084-9282363:-.alignment |
| chr11:9288989-9294461:- | ENST00000299596.7 | ENSG00000166471.9 | TMEM41B | intronic | AluSx,AluJo,AluSz6,AluSg7,AluSc,AluJr,AluJb,L1MC5a,(AC)n,L1PA6,L1MC5,A-rich,AluSc8,(ATA)n,AluYc,AluSq,AluSp,L1M3 | chr11:9288989-9294461:-.alignment |
| chr11:9288989-9294461:- | ENST00000524543.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx,AluJo,AluSz6,AluSg7,AluSc,AluJr,AluJb,L1MC5a,(AC)n,L1PA6,L1MC5,A-rich,AluSc8,(ATA)n,AluYc,AluSq,AluSp,L1M3 | chr11:9288989-9294461:-.alignment |
| chr11:9288989-9294461:- | ENST00000527813.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx,AluJo,AluSz6,AluSg7,AluSc,AluJr,AluJb,L1MC5a,(AC)n,L1PA6,L1MC5,A-rich,AluSc8,(ATA)n,AluYc,AluSq,AluSp,L1M3 | chr11:9288989-9294461:-.alignment |
| chr11:9288989-9294461:- | ENST00000528080.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx,AluJo,AluSz6,AluSg7,AluSc,AluJr,AluJb,L1MC5a,(AC)n,L1PA6,L1MC5,A-rich,AluSc8,(ATA)n,AluYc,AluSq,AluSp,L1M3 | chr11:9288989-9294461:-.alignment |
| chr11:9288989-9294461:- | ENST00000611268.3 | ENSG00000166471.9 | TMEM41B | intronic | AluSx,AluJo,AluSz6,AluSg7,AluSc,AluJr,AluJb,L1MC5a,(AC)n,L1PA6,L1MC5,A-rich,AluSc8,(ATA)n,AluYc,AluSq,AluSp,L1M3 | chr11:9288989-9294461:-.alignment |
| chr11:9303724-9303954:- | ENST00000299596.7 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9303724-9303954:- | ENST00000524543.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9303724-9303954:- | ENST00000527813.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9303724-9303954:- | ENST00000528080.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9303724-9303954:- | ENST00000533723.1 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9303724-9303954:- | ENST00000611268.3 | ENSG00000166471.9 | TMEM41B | intronic | AluSx | chr11:9303724-9303954:-.alignment |
| chr11:9308194-9309172:- | ENST00000299596.7 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| chr11:9308194-9309172:- | ENST00000524543.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| chr11:9308194-9309172:- | ENST00000527813.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| chr11:9308194-9309172:- | ENST00000528080.4 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| chr11:9308194-9309172:- | ENST00000533723.1 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| chr11:9308194-9309172:- | ENST00000611268.3 | ENSG00000166471.9 | TMEM41B | intronic | AluSp,AluSz | chr11:9308194-9309172:-.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| ENSG00000166471.9,TMEM41B | BLCA | EAG | Monocytes | 1.5194e-02 | -0.4464 |  |
| chr11:9288989-9294461:- | BRCA | EER | Macrophages_M1 | 9.6407e-04 | 0.2420 |  |
| ENSG00000166471.9,TMEM41B | BRCA | EAG | Macrophages_M1 | 2.4697e-03 | 0.2134 |  |
| chr11:9288989-9294461:- | COAD | EER | T_cells_follicular_helper | 3.5671e-02 | 0.3072 |  |
| ENSG00000166471.9,TMEM41B | COAD | EAG | T_cells_follicular_helper | 3.0615e-02 | 0.3157 |  |
| chr11:9288989-9294461:- | ESCA | EER | T_cells_follicular_helper | 2.2828e-02 | 0.2275 |  |
| ENSG00000166471.9,TMEM41B | KIRC | EAG | Plasma_cells | 2.4723e-02 | -0.3547 |  |
| chr11:9288989-9294461:- | LAML | EER | Neutrophils | 7.3585e-03 | 0.2777 |  |
| ENSG00000166471.9,TMEM41B | LAML | EAG | Neutrophils | 1.1363e-02 | 0.2587 |  |
| ENSG00000166471.9,TMEM41B | LGG | EAG | Plasma_cells | 3.0409e-02 | 0.3664 |  |
| chr11:9288989-9294461:- | LUAD | EER | NK_cells_activated | 1.3112e-02 | -0.2130 |  |
| ENSG00000166471.9,TMEM41B | LUAD | EAG | NK_cells_activated | 1.1510e-03 | -0.2720 |  |
| chr11:9288989-9294461:- | OV | EER | T_cells_regulatory_(Tregs) | 1.4896e-02 | 0.3777 | .chr11_9288989-9294461_-.png) |
| ENSG00000166471.9,TMEM41B | PRAD | EAG | T_cells_CD8 | 3.9980e-02 | 0.4514 |  |
| chr11:9288989-9294461:- | STAD | EER | T_cells_CD4_memory_activated | 1.1468e-03 | 0.2510 |  |
| ENSG00000166471.9,TMEM41B | STAD | EAG | T_cells_CD4_memory_activated | 1.6786e-03 | 0.2265 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000166471.9,TMEM41B | BRCA | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 1.0583e-02 | 0.1808 |  |
| chr11:9288989-9294461:- | BRCA | GSVA_HALLMARK_COAGULATION | EER | 1.2153e-02 | 0.1850 |  |
| ENSG00000166471.9,TMEM41B | COAD | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 5.1120e-03 | 0.4018 |  |
| chr11:9288989-9294461:- | COAD | GSVA_HALLMARK_P53_PATHWAY | EER | 5.3653e-03 | 0.3998 |  |
| ENSG00000166471.9,TMEM41B | ESCA | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 7.2012e-03 | -0.2549 |  |
| ENSG00000166471.9,TMEM41B | KIRC | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 1.3564e-02 | -0.3872 |  |
| chr11:9288989-9294461:- | LAML | GSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE | EER | 6.7771e-05 | 0.4031 |  |
| ENSG00000166471.9,TMEM41B | LAML | GSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE | EAG | 3.3033e-04 | 0.3607 |  |
| ENSG00000166471.9,TMEM41B | LGG | GSVA_HALLMARK_IL6_JAK_STAT3_SIGNALING | EAG | 2.9900e-02 | -0.3674 |  |
| chr11:9288989-9294461:- | LUAD | GSVA_HALLMARK_APICAL_SURFACE | EER | 1.6814e-05 | 0.3612 |  |
| ENSG00000166471.9,TMEM41B | LUAD | GSVA_HALLMARK_APICAL_SURFACE | EAG | 2.3644e-05 | 0.3491 |  |
| ENSG00000166471.9,TMEM41B | PRAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 3.3709e-02 | 0.4649 |  |
| chr11:9303724-9303954:- | STAD | GSVA_HALLMARK_ANGIOGENESIS | EER | 3.9102e-02 | 0.4427 |  |
| chr11:9288989-9294461:- | STAD | GSVA_HALLMARK_ANGIOGENESIS | EER | 7.5483e-03 | 0.2073 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| ENSG00000166471.9,TMEM41B | BLCA | CI.1040 | EAG | 3.9075e-02 | 0.3852 |  |
| ENSG00000166471.9,TMEM41B | BRCA | AZD8055 | EAG | 9.0375e-03 | -0.1846 |  |
| chr11:9288989-9294461:- | BRCA | BMS.509744 | EER | 4.1078e-04 | -0.2585 |  |
| ENSG00000166471.9,TMEM41B | COAD | AKT.inhibitor.VIII | EAG | 1.3597e-03 | 0.4537 |  |
| chr11:9288989-9294461:- | COAD | AKT.inhibitor.VIII | EER | 1.3296e-03 | 0.4545 |  |
| ENSG00000166471.9,TMEM41B | ESCA | CHIR.99021 | EAG | 1.3863e-03 | 0.3012 |  |
| chr11:9288989-9294461:- | ESCA | BMS.754807 | EER | 2.9050e-04 | 0.3550 |  |
| ENSG00000166471.9,TMEM41B | KIRC | Lapatinib | EAG | 1.7620e-02 | -0.3734 |  |
| chr11:9288989-9294461:- | LAML | CI.1040 | EER | 2.4039e-03 | -0.3127 |  |
| ENSG00000166471.9,TMEM41B | LAML | JNK.9L | EAG | 1.2375e-02 | -0.2557 |  |
| ENSG00000166471.9,TMEM41B | LGG | GW.441756 | EAG | 6.3701e-04 | -0.5490 |  |
| chr11:9288989-9294461:- | LUAD | ABT.888 | EER | 1.9281e-02 | 0.2012 |  |
| ENSG00000166471.9,TMEM41B | LUAD | GDC0941 | EAG | 8.5078e-03 | -0.2216 |  |
| chr11:9288989-9294461:- | LUSC | Docetaxel | EER | 1.1950e-02 | -0.2505 |  |
| ENSG00000166471.9,TMEM41B | LUSC | Docetaxel | EAG | 1.5373e-02 | -0.2394 |  |
| chr11:9288989-9294461:- | OV | Bryostatin.1 | EER | 1.5694e-02 | 0.3750 |  |
| ENSG00000166471.9,TMEM41B | OV | Erlotinib | EAG | 1.4056e-02 | 0.3355 |  |
| ENSG00000166471.9,TMEM41B | PRAD | AZD.2281 | EAG | 3.2876e-03 | 0.6105 |  |
| ENSG00000166471.9,TMEM41B | STAD | AZD6482 | EAG | 9.3507e-03 | -0.1881 |  |
| chr11:9288989-9294461:- | STAD | Midostaurin | EER | 1.4533e-02 | -0.1900 |  |
| ENSG00000166471.9,TMEM41B | THCA | DMOG | EAG | 8.7806e-03 | 0.4556 |  |